European countries resume use of AstraZeneca COVID vaccine after blot clot pause

Nearly a dozen countries have resumed use of AstraZeneca’s COVID-19 shots as EU and British regulators say the benefits outweigh any risks.

The U-turn comes after reports of rare instances of blood clotting that temporarily halted inoculations.

Find out all the latest about COVID-19 in the video above

The end of suspensions will kick off a test of public confidence, both in the shot and in drug regulators whose conclusions are under unprecedented scrutiny.

Virus variants continue to spread and the global death toll is now at nearly 2.7 million and rising.

Indonesia joined Germany, France and others in re-administering the shots after they suspended vaccinations on reports of around 30 cases of rare brain blood clots, after millions of injections.

That sent scientists and governments scrambling to determine if there was a link.

The European Medicines Agency (EMA) came to what it called a clear conclusion that the vaccine’s benefits in protecting people from coronavirus-related death or hospitalisation outweighed the possible risks.

Countries are resuming use of AstraZeneca’s COVID-19 shots. Credit: REUTERS

What's your reaction?

In Love
Not Sure

You may also like

More in:Lifestyle

Leave a reply

Your email address will not be published. Required fields are marked *